Jim Hoffman: Linking Post-Acute Chronic Infection Brain Injury and Autoimmune Dysregulation
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared a post on LinkedIn:
“Outstanding videocast by Craig Shimaski, detailing the link between post-acute chronic infection brain injury and autoimmune dysregulation.
Autoimmune encephalopathy can also be triggered by the onset of cancer in genetically predisposed individuals.
A likely common link to autoimmune brain injury triggered by cancer and pathogenic infection is exacerbated ‘NETosis dysregulation‘ that may be able to be treated more directly and effectively with extracorporeal removal of Neutrophil Extracellular Traps (NETs) and extracellular chromatin released by other damaged and dying cells, into the blood circulation.
We need earlier diagnosis and improved early interventional therapies that can potentially mitigate debilitating and life-threatening chronic neurodegenerative autoimmune-mediated injury known to cause debilitating neurological motor and cognitive impairment, including better treatment for severe mental illness that often leads to suicidal and violent schizophrenia.
I will attach previous posts I have made in the comments section, including pioneering research, as to why we should be prognostically tracking and clinically trialing NET and extracellular chromatin removal therapies for serious post-acute chronic infections and the suspected development of cancer.
Not only to potentially mitigate the progression to severe sepsis or advanced- stage cancer but also to potentially reduce the risk of secondary brain and CNS and other secondary organ injuries that result from chronic NETosis dysregulation and impaired efferocytosis self-sufficiency.”
Other posts featuring Jim Hoffman on Hemostasis Today.
-
Oct 25, 2026, 17:43Jan Sloves: Femoral Vein Aneurysm and Chronic Venous Obstruction
-
Oct 25, 2026, 17:31Kasimu Hussaini: Blood Component Therapy From Whole Blood to Targeted Treatment
-
Oct 25, 2026, 17:23Zahra Safarzadeh: When Low Factor VII Activity and Reduced VWF Antigen Coexist
-
Oct 25, 2026, 17:17Anubhav Joshi: Evans Syndrome in CLL A Differential Diagnosis to Remember
-
Oct 25, 2026, 17:04Tehila Alter: Tracking Hematopoietic Cell Engraftment in Bone Marrow Using CEST MRI
-
Oct 25, 2026, 16:45Shauna RileyÖ‰ First Guidelines for Hemoglobin SC Disease
-
Oct 25, 2026, 16:26Heghine Khachatryan: Patient Safety and Clinical Judgment in Platelet Transfusion Decisions
-
Oct 25, 2026, 16:13Funmi (Vanessa) Ullam: From Lived Experience to Research and Innovation in Sickle Cell Care
-
Oct 25, 2026, 15:13Franky Biles: Celebrating Diversity and Driving Inclusion Through Representation